Caprock Group, Inc. Veracyte, Inc. Transaction History
Caprock Group, Inc.
- $2.71 Billion
- Q3 2024
A detailed history of Caprock Group, Inc. transactions in Veracyte, Inc. stock. As of the latest transaction made, Caprock Group, Inc. holds 7,407 shares of VCYT stock, worth $288,428. This represents 0.01% of its overall portfolio holdings.
Number of Shares
7,407Holding current value
$288,428% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding VCYT
# of Institutions
308Shares Held
81.8MCall Options Held
134KPut Options Held
13.3K-
Black Rock Inc. New York, NY7.79MShares$303 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.75MShares$302 Million0.0% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI5.02MShares$196 Million0.27% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl4.92MShares$192 Million1.59% of portfolio
-
Wellington Management Group LLP Boston, MA4.23MShares$165 Million0.03% of portfolio
About VERACYTE, INC.
- Ticker VCYT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,575,904
- Market Cap $2.79B
- Description
- Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...